Compare AbbVie Inc (ABBV) vs Arista Networks Inc (ANET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbbVie Inc vs Arista Networks Inc — how do they compare? AbbVie Inc trades at $248.68 (market cap $438.19B), while Arista Networks Inc trades at $201.8 (market cap $241.55B). The key difference: AbbVie Inc is the larger of the two by market cap, and AbbVie Inc pays a 2.79% dividend while Arista Networks Inc pays none. Which is the better fit depends on your goals.
| ABBV | ANET | |
|---|---|---|
Market Cap | $438.19B | $241.55B |
Sector | Health | Technology |
52-Week High | $263.58 | $197.85 |
52-Week Low | $197.38 | $116.13 |
Enterprise Value | $502.45B | $228.21B |
Dividend Yield | 2.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABBV trades at $247.91, up 0.76% today, with a bullish technical signal supported by moving averages and oversold RSI levels. The company reported Q2 2026 EPS of $3.65, beating expectations, and maintains strong profitability with a 71.48% gross margin. Recent news highlights positive Phase 2 data for ELAHERE in ovarian cancer, reinforcing growth prospects beyond Humira's patent expiry.
Outlook is positive with analyst consensus target of $278.69, though high P/E of 70.05 and debt levels pose valuation and financial risks. Revenue growth driven by Skyrizi and Rinvoq offsets competitive pressures, but patent cliffs in the 2030s require monitoring. The stock offers dividend appeal with a $1.73 payout scheduled for August 2026.
Arista Networks (ANET) trades at $188.67, down 1.9% over 24 hours, with a bullish technical outlook supported by moving averages. The stock shows strong fundamentals, with revenue growing from $4.4B in 2022 to $9.0B in 2025 and a net income margin of 38.37%. Recent earnings beats and raised 2026 guidance reflect robust AI-driven demand from hyperscalers like Meta and Microsoft.
Outlook remains positive due to AI data center expansion and Ethernet market growth, but high valuation multiples (P/E 59.71) pose risks if execution falters. Analyst consensus is strongly bullish with a $252.25 price target, though insider selling and competition require monitoring for sustained gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About Arista Networks Inc
Arista Networks is a software and hardware provider for the networking solutions sector. Operating as one business unit, software, switching, and router products are targeted for high-performance networking applications, while service revenue comes from technical support. Customer markets include data centers, enterprises, service providers, and campuses. The company is headquartered in Santa Clara, California, and generates most of its revenue in the Americas.
Read more on ANET →
